Kyle McAnally

Beth Israel Deaconess Medical Center

Papers

4

Total Citations

59

H-Index

4

About

Kyle McAnally is a urologic surgeon and researcher whose work centers on improving patient outcomes in prostate and kidney cancer surgery, with a focus on quality of life, opioid stewardship, and surgical technique. He is best known for validating the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP), a short questionnaire that enables point-of-care assessment of patient-reported quality of life after robot-assisted radical prostatectomy—a tool that has garnered over 30 citations and is now used in routine clinical care. McAnally has also advanced nephron-sparing surgery by demonstrating that the early unclamping technique during robotic partial nephrectomy significantly reduces pseudoaneurysm and urine leak rates (16 citations). In response to the opioid epidemic, he led a quality improvement initiative that successfully reduced postoperative opioid pill prescribing, addressing barriers to adoption and contributing to safer surgical recovery (8 citations). His work on preoperative pelvic floor assessment to predict early return of continence after prostatectomy (5 citations) further underscores his commitment to personalized, functional outcomes. McAnally’s research bridges surgical innovation with practical, patient-centered care, making a tangible impact on urologic practice.

Research Focus

Key Achievements

4
H-Index
4
Papers
59
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Clinical Use of Expanded Prostate Cancer Index Composite for Clinical Practice to Assess Patient Reported Prostate Cancer Quality of Life Following Robot-Assisted Radical Prostatectomy
30 citations · 2016
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 33
🏛 Institutions: Beth Israel Deaconess Medical Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago